ISOPURE

ISOPURE INFUSIONS Mixed Berry

D
N+ Score63
ProteinServing: 25 Gram(s)Type: Amino acid/Protein [A1305]

ISOPURE INFUSIONS Mixed Berry is a protein supplement, offering a simple profile for protein intake. Each 25-gram serving delivers 20 grams of protein, 90 calories, 2 grams of total carbohydrates, and 10 mg of cholesterol. This product received an N+ Score of 63 and a D grade, placing it in the average tier for quality and efficacy. The analysis shows an ingredient adequacy of 50% and formula completeness of 33%, indicating a focused, rather than comprehensive, nutrient blend. With 6 total ingredients and strong label transparency at 83%, consumers can easily understand the product's composition. No ingredients are specified as being at clinically effective doses. This product is suitable for individuals prioritizing a straightforward protein source with a berry flavor.

About This Product

ISOPURE INFUSIONS Mixed Berry by ISOPURE is a protein supplement containing 6 active ingredients. It has earned an N+ Score of 63/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency83/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (6 ingredients)

IngredientAmountDose Adequacy
Calories90.000 Calorie(s)N/A
Total FatN/A
Total Carbohydrates2.000 Gram(s)N/A
Sodium15.000 mgN/A
Cholesterol10.000 mgN/A
Protein20.000 Gram(s)N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.